YU199691A - Receptor za humani interleukin-5 - Google Patents

Receptor za humani interleukin-5

Info

Publication number
YU199691A
YU199691A YU199691A YU199691A YU199691A YU 199691 A YU199691 A YU 199691A YU 199691 A YU199691 A YU 199691A YU 199691 A YU199691 A YU 199691A YU 199691 A YU199691 A YU 199691A
Authority
YU
Yugoslavia
Prior art keywords
receptor
human interleukin
receptors
host cells
parts
Prior art date
Application number
YU199691A
Other languages
English (en)
Serbian (sr)
Inventor
R. Devos
W. Fiers
G. Plaetinck
J. Tavernier
J. Van Der Heyden
Original Assignee
F.Hoffmann-La Roche Ag.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F.Hoffmann-La Roche Ag. filed Critical F.Hoffmann-La Roche Ag.
Publication of YU199691A publication Critical patent/YU199691A/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

RECEPTOR ZA HUMANI INTERLEUKIN-5, cilj ovog pronalaska je da omogući dobijanje rekombinantnog alfa-lanca receptora za humani interleukin 5 ili njegovih delova, sekvence DNK koje kodiraju za takav receptor ili njegove delove, ćelije-domaćine koji su transformisane takvim vektorima i postupak za proizvodnju takvih alfalanaca receptora za humani interleukin 5 kristeći takve transformisane ćelije-domaćine i farmaceutske smeše koje sadrže takve receptore ili njihove fragmente i njihovu primenu u lečenju bolesti, na primer hronične astme.
YU199691A 1990-12-27 1991-12-26 Receptor za humani interleukin-5 YU199691A (sh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP90811030 1990-12-27
EP91810327 1991-04-30

Publications (1)

Publication Number Publication Date
YU199691A true YU199691A (sh) 1994-06-24

Family

ID=26127858

Family Applications (1)

Application Number Title Priority Date Filing Date
YU199691A YU199691A (sh) 1990-12-27 1991-12-26 Receptor za humani interleukin-5

Country Status (16)

Country Link
EP (1) EP0492214A3 (sh)
JP (1) JP2554418B2 (sh)
KR (1) KR920012440A (sh)
AR (1) AR246310A1 (sh)
AU (1) AU647560B2 (sh)
CA (1) CA2058003A1 (sh)
FI (1) FI916067A (sh)
HU (1) HUT59725A (sh)
IE (1) IE914548A1 (sh)
IL (1) IL100470A0 (sh)
MX (1) MX9102767A (sh)
NO (1) NO915084L (sh)
NZ (1) NZ241094A (sh)
PT (1) PT99929A (sh)
TW (1) TW280833B (sh)
YU (1) YU199691A (sh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5453491A (en) * 1990-09-11 1995-09-26 Kiyoshi Takatsu Murine interleukin-5 receptor
US5976790A (en) 1992-03-04 1999-11-02 The Regents Of The University Of California Comparative Genomic Hybridization (CGH)
US5668110A (en) * 1995-06-07 1997-09-16 Affymax Technologies N.V. Peptides and compounds that bind to the IL-5 receptor
US5654276A (en) * 1995-06-07 1997-08-05 Affymax Technologies N.V. Peptides and compounds that bind to the IL-5 receptor
US5683983A (en) * 1995-06-07 1997-11-04 Glaxo Group Limited Peptides and compounds that bind to the IL-5 receptor
US5677280A (en) * 1995-06-07 1997-10-14 Glaxo Group Limited Peptides and compounds that bind to the IL-5 receptor
AU690474B2 (en) 1995-09-11 1998-04-23 Kyowa Hakko Kirin Co., Ltd. Antibody againts alpha-chain of human interleukin 5 receptor
US7455964B1 (en) 1996-07-15 2008-11-25 The Hospital For Sick Children Genes from the 20q13 amplicon and their uses
US7049424B2 (en) 1996-07-15 2006-05-23 The Regents Of The University Of California Genes from the 20Q13 amplicon and their uses
WO1997026332A1 (en) * 1996-01-17 1997-07-24 Schering Corporation Baculovirus expression system for human interleukin 5 receptor and method of screening for interleukin 5 antagonists
US5861279A (en) * 1996-01-17 1999-01-19 Schering Corporation Baculovirus expression system for human interleukin 5 receptor and method of screening for interleukin 5 antagonists
FR2783326B1 (fr) * 1998-09-10 2000-12-01 Immunotech Sa Procede de detection ou de quantification des basophiles et des eosinophiles
US7109299B1 (en) 1999-12-16 2006-09-19 Affymax, Inc. Peptides and compounds that bind to the IL-5 receptor

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5453491A (en) * 1990-09-11 1995-09-26 Kiyoshi Takatsu Murine interleukin-5 receptor

Also Published As

Publication number Publication date
CA2058003A1 (en) 1992-06-28
NO915084L (no) 1992-06-29
HUT59725A (en) 1992-06-29
AU8998591A (en) 1992-10-15
NZ241094A (en) 1993-07-27
KR920012440A (ko) 1992-07-27
MX9102767A (es) 1992-06-30
HU913961D0 (en) 1992-02-28
EP0492214A3 (en) 1992-09-09
AU647560B2 (en) 1994-03-24
NO915084D0 (no) 1991-12-23
JPH0678772A (ja) 1994-03-22
TW280833B (sh) 1996-07-11
IE914548A1 (en) 1992-07-01
FI916067A0 (fi) 1991-12-20
FI916067A (fi) 1992-06-28
EP0492214A2 (en) 1992-07-01
AR246310A1 (es) 1994-07-29
JP2554418B2 (ja) 1996-11-13
IL100470A0 (en) 1992-09-06
PT99929A (pt) 1993-01-29

Similar Documents

Publication Publication Date Title
Nyirkos et al. Human synovial cells secrete a 39 kDa protein similar to a bovine mammary protein expressed during the non-lactating period
YU199691A (sh) Receptor za humani interleukin-5
DE69230993T2 (de) Rekombinante viren vektoren zur expression in muskelzellen
Schröder et al. IL-1 alpha or tumor necrosis factor-alpha stimulate release of three NAP-1/IL-8-related neutrophil chemotactic proteins in human dermal fibroblasts.
BG64881B2 (en) TNF-BINDING PROTEINS
DE60125381D1 (de) Zusammensetzungen und verfahren mit analogen von g-csf
DK0423302T3 (da) Anvendelse af hidtil ukendte DNA-fragmenter som kodende sekvens for et signalpeptid til sekretion af modne proteiner i rekombinant gær, ekspressionskassetter, transformeret gær og tilsvarende fremgangsmåde til fremstilling af proteiner
NZ337955A (en) Modified TNF-alpha and their use as vaccines
MY102029A (en) Human factor viii, compositions containing it, methods and materials for use in its production
ATE122397T1 (de) Fusionsproteine aus interleukin-2 und hirudin.
MX9301700A (es) Muteinas del factor de necrosis tumoral humano, procedimiento para su preparacion y composiciones farmaceuticas que las contienen.
HUP0003563A2 (hu) Aminoterminálisa felől csonkolt MCP-2 mint kemokinantagonista
IT1298487B1 (it) Composizioni farmaceutiche comprendenti pentraxina lunga ptx3 per la terapia di patologie di tipo infettivo, infiammatorio o tumorale,
PT666914E (pt) Nova proteina ligando da selectina p
DE59610632D1 (de) Varianten des humanen rekombinanten interferon-gamma (rhu-ifn-gamma) mit erhöhter thermischer stabilität
HUP0100456A1 (hu) IFNAR2/IFN komplex, alkalmazásai és a komplexet tartalmazó készítmények
DE69736276D1 (de) Menschliche dnase resistent gegen actininhibitoren
DE59108947D1 (de) Neues menschliches, rekombinantes interferon gamma
DK0946591T3 (da) Klonede glucagon-lignende peptid-2 receptorer
ATE230027T1 (de) Menschliche dnase i varianten
FI950883A (fi) BAPP-C100-reseptorin kloonaus ja ilmentäminen
BR0012740A (pt) Compostos para tratamento de distúrbios do sistema infeccioso e imune e métodos para seu emprego
MA23755A1 (fr) Cyclohexanes-1-ols disubstitues en 4,4 monomeres et composes similaires
YU182791A (sh) Tnf-muteini
KR910009280A (ko) 원발성 흉막암 치료용 제약 조성물의 제조에 있어서 감마 인터페론 활성을 갖는 폴리펩티드의 용도